ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ATXI stock results show that Avenue Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
The post ATXI Stock Earnings: Avenue Therapeutics Misses EPS for Q2 2024 appeared first on InvestorPlace.
More From InvestorPlace